Academic Health Center
Stay Connected
research-and-clinical-trials

Research snapshot: E-cigarettes may result in lower consumed toxicants for users, says new UMN research

E-cigarettes are a quickly growing market, and potentially for good reason. New research out of the Masonic Cancer Center, University of Minnesota shows the metabolized levels of disease-causing compounds are significantly lower in e-cigarettes than traditional cigarettes.

Read more
news-and-notes

UMN mourns loss of Lee Wattenberg, M.D., recognized as the “father of chemoprevention”

The faculty and staff of the University of Minnesota and the Masonic Cancer Center, University of Minnesota are mourning the loss of cancer pioneer Lee Wattenberg, M.D. Wattenberg died December 9 at the age of 92, and will be remembered for his immense contribution to the field of chemoprevention.

Wattenberg is credited with the creation of an entire field of research in the wake of his landmark 1966 paper in Cancer Research examining the effects of certain compounds on cancer development.  This led to a new emphasis on understanding cancer prevention, including the use of foods such as cabbage and broccoli to try to prevent cancer.

Read more
expert-perspectives

What does broccoli sprout tea have to do with cancer?

From a young age, kids are taught to eat their vegetables for the healthy benefits they pose. Now research is suggesting cruciferous vegetables like broccoli sprouts could offer more gains — cancer prevention.

Stephen Hecht, Ph.D., a University of Minnesota professor of laboratory medicine and pathology, and member of the Masonic Cancer Center, University of Minnesota, conducts research focusing on tobacco-related cancer prevention. He recently was part of a different kind of groundbreaking research finding the right diet has the ability to decrease risks of developing certain types of cancer.

Read more
education

50 years out: Will your genes define your Rx?

Tylenol should relieve pain, cough suppressants should ease cough and serious ailments should reliably respond to vital medication. But when a prescribed medicine doesn’t do its intended job, it can be difficult to decide who or what is to blame.

It doesn’t help that sometimes the problem doesn’t lie within the medicine or the doctor; it can lie within your genes.

Read more
research-and-clinical-trials

Master regulator of key cancer gene found, offers new drug target

Gene partnership may be fueling cancer spread in as much as 20 percent of cancers

A key cancer-causing gene, responsible for up to 20 percent of cancers, may have a weak spot in its armor, according to new research from the Masonic Cancer Center, University of Minnesota.

The partnership of MYC, a gene long linked to cancer, and a non-coding RNA, PVT1, could be the key to understanding how MYC fuels cancer cells. The research is published in the latest issue of the journal Nature.

Read more
research-and-clinical-trials

U of M research finds kava plant may prevent cigarette smoke-induced lung cancer

New research from the University of Minnesota College of Pharmacy and Masonic Cancer Center has found that consumption of the root of Piper methysticum, or kava, a plant native to the South Pacific Islands, may prevent the development of tobacco smoke-induced lung cancer.

Read more